Ocular Therapeutix Inc
NASDAQ:OCUL
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.23
11.47
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Ocular Therapeutix Inc
Wall Street
Price Targets
OCUL Price Targets Summary
Ocular Therapeutix Inc
According to Wall Street analysts, the average 1-year price target for
OCUL
is 18.59 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
OCUL Last Price Targets
Ocular Therapeutix Inc
The latest public price target was made on Aug 8, 2024 by
Colleen Kusy
from
Robert W. Baird
,
who expects
OCUL
stock to
rise by 93%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Colleen Kusy
Robert W. Baird
|
17
USD
Upside 93% |
3 months ago
Aug 8, 2024
|
Ocular Therapeutix price target lowered to $17 from $18 at Baird
TheFly
|
Biren Amin
Piper Sandler
|
15
USD
Upside 70% |
4 months ago
Jun 27, 2024
|
Piper Sandler Reiterates Overweight Rating on Ocular Therapeutix (OCUL)
StreetInsider
|
|
Yi Chen
H.C. Wainwright
|
14
USD
Upside 59% |
5 months ago
Jun 14, 2024
|
H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
StreetInsider
|
Jonathan Wolleben
JMP Securities
|
24
USD
Upside 172% |
8 months ago
Mar 12, 2024
|
Ocular Therapeutix (OCUL) PT Raised to $24 at JMP Securities
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OCUL's stock price target?
Price Target
18.59
USD
According to Wall Street analysts, the average 1-year price target for
OCUL
is 18.59 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
What is Ocular Therapeutix Inc's Revenue forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Ocular Therapeutix Inc's revenue is
55%.
The projected
CAGR
for the next 3 years is
18%.
You don't have any saved screeners yet
